AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 0.69 |
Market Cap | 15.29M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.64 |
PE Ratio (ttm) | -1.09 |
Forward PE | n/a |
Analyst | Buy |
Ask | 0.71 |
Volume | 640,126 |
Avg. Volume (20D) | 986,000 |
Open | 0.74 |
Previous Close | 0.71 |
Day's Range | 0.67 - 0.74 |
52-Week Range | 0.50 - 2.50 |
Beta | undefined |
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices t...
Analyst Forecast
According to 2 analyst ratings, the average rating for EKSO stock is "Buy." The 12-month stock price forecast is $5.5, which is an increase of 691.37% from the latest price.
Next Earnings Release
Analysts project revenue of $5.30M, reflecting a 9.35% YoY growth and earnings per share of -0.08, making a -63.64% decrease YoY.
2 months ago · seekingalpha.com
Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call TranscriptEkso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q3 2024 Earnings Conference Call October 28, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome...